Viewing Study NCT01414205


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2025-12-26 @ 2:00 AM
Study NCT ID: NCT01414205
Status: COMPLETED
Last Update Posted: 2017-04-17
First Post: 2011-08-10
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)
Sponsor: Genentech, Inc.
Organization: